Literature DB >> 2861896

Clinical diversity in adult T-cell leukemia-lymphoma.

K Takatsuki, K Yamaguchi, F Kawano, T Hattori, H Nishimura, H Tsuda, I Sanada, K Nakada, Y Itai.   

Abstract

Adult T-cell leukemia-lymphoma (ATL) is a unique T-cell cancer first described in Japan. We estimate that more than 200 patients a year have been detected in Kyushu. The surface phenotype of ATL cells characterized by monoclonal antibodies is T3+, T4+, T8-, T11+, and Tac+. In all cases the serum is positive for anti-human T-cell leukemia (lymphotropic) virus (HTLV-I) antibodies and the ATL cells contain the proviral DNA of HTLV-I. Variations in the clinical features of atypical cases suggest a division of the spectrum of ATL into five types: acute (prototypic), chronic, smoldering, crisis, and lymphoma. Screening of the sera from healthy adults for presence of the anti-HTLV-I antibodies revealed that 3.6% of healthy individuals in Kumamoto Prefecture, which is located in the middle of Kyushu, were HTLV-I carriers. The percentage of positivity increased with age and was higher in females than in males. It varied from town to town, ranging from 0 to 17.6%. Family studies showed that the routes of natural infection of HTLV-I are from mother to child and also from husband to wife. The third route is blood transfusion. The borderline between the healthy carrier state and smoldering ATL remains unclear. In the endemic areas smoldering ATL is frequently diagnosed in patients with fungus infection of the skin, chronic lymphadenopathy, interstitial pneumonitis, chronic renal failure, and strongyloidiasis. In addition our experiences with a concurrence of lymphoma-type ATL in three sisters and spontaneous remissions in a patient with chronic ATL are cited.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2861896

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  22 in total

1.  Human T-cell lymphotropic virus-associated primary gastric lymphoma.

Authors:  H Sakata; R Iwakiri; T Koyama; T Yoshida; K Okamoto; K Miyazaki; T M Mizuguchi; S Kudo; O Tokunaga; K Fujimoto
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

2.  Transmission of human T-cell leukemia virus type 1 to mice.

Authors:  J Fang; S Kushida; R Feng; M Tanaka; T Kawamura; H Abe; N Maeda; M Onobori; M Hori; K Uchida; M Miwa
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  A seroepidemiologic survey of human T-cell lymphotropic virus type I in two Hawaiian hematologic-oncologic practices.

Authors:  J T Kimata; S A Kaneshiro; D W Kwock; S Nakamura; M M Kaneshiro; J M Nakamura
Journal:  West J Med       Date:  1989-03

4.  Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.

Authors:  S Matsushita; H Mitsuya; M S Reitz; S Broder
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

5.  Tax 1-independent induction of vascular endothelial growth factor in adult T-cell leukemia caused by human T-cell leukemia virus type 1.

Authors:  Karen M Watters; Jonathan Dean; Virginie Gautier; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

Review 6.  Molecular biology and pathogenesis of the human T-cell leukaemia/lymphotropic virus Type-1 (HTLV-1).

Authors:  J M Johnson; R Harrod; G Franchini
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

7.  PDZ binding motif of HTLV-1 Tax promotes virus-mediated T-cell proliferation in vitro and persistence in vivo.

Authors:  Li Xie; Brenda Yamamoto; Abdelali Haoudi; O John Semmes; Patrick L Green
Journal:  Blood       Date:  2005-11-01       Impact factor: 22.113

Review 8.  T-cell control by human T-cell leukemia/lymphoma virus type 1.

Authors:  Genoveffa Franchini; Risaku Fukumoto; Jake R Fullen
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

9.  Synthesis of a novel cytokine and its gene (LD78) expressions in hematopoietic fresh tumor cells and cell lines.

Authors:  Y Yamamura; T Hattori; K Obaru; K Sakai; N Asou; K Takatsuki; Y Ohmoto; H Nomiyama; K Shimada
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

10.  Suppression of human T-cell leukemia virus I gene expression by pokeweed antiviral protein.

Authors:  Sheila Mansouri; Gunjan Choudhary; Paulina M Sarzala; Lee Ratner; Katalin A Hudak
Journal:  J Biol Chem       Date:  2009-09-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.